Imperial Tech
Imperial Innovations is a technology commercialization and venture capital investor that focuses on technology.
Business Model:
Revenue: $1M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Imperial Tech Information
Geographic Data
Address: Exhibition Rd,
City: London
State: england
Zip: SW7 2AZ
Country: GB
Financial Info
Stage:
Raised Last:
$0
Raised Total:$343M
Social
Metrics
4,303,734Website Global Rank
2,426Website Monthly Traffic
Twitter Followers
Description
Imperial Innovations is a technology commercialization and venture capital investor that focuses on technology. Imperial Innovations no longer invests in startups and now functions as the technology-transfer office of Imperial College. Imperial Innovations is focused on commercialising leading UK academic research sourced from the &s;golden triangle&s; formed between Cambridge, Oxford and London. We are a technology commercialisation company that combines the activities of technology transfer, intellectual property protection and licensing, company incubation and investment. Innovations is focused on commercialising the most promising UK academic research across a broad range of technology sectors, and has developed particular expertise in: therapeutics, medtech, engineering and materials and information communication technology.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2006 | Midaz Lasers | Seed Round | - |
| 12/2013 | Econic Technologies | Series A | 8.4M |
| 3/2007 | Southside Thermal Sciences | Venture Round | 2.4M |
| 9/2016 | Concirrus | Series A | 0 |
| 12/2013 | Crescendo Biologics | Series A | 28.5M |
| 12/2005 | Veryan Medical | Series A | 2.2M |
| 1/2012 | Cambridge Communication Systems | Seed Round | 2M |
| 12/2011 | Chirp | Seed Round | - |
| 6/2015 | Auspherix | Series A | 9.2M |
| 4/2015 | Yoyo Wallet | Series A | 10M |
| 1/2010 | BioCeramic Therapeutics | Series B | 1.9M |
| 5/2016 | Inflowmatix | Series A | 4.4M |
| 7/2007 | NanoBioDesign | Venture Round | 1M |
| 2/2016 | Aqdot | Series A | 7.2M |
| 6/2012 | Oxford Immunotec | Equity | 28M |
| 9/2007 | Molecular Vision | Venture Round | 500k |
| 3/2012 | Abingdon Health | Venture Round | 4.8M |
| 4/2008 | Spiral Gateway | Series C | 1.4M |
| 7/2016 | Econic Technologies | Venture Round | 6.5M |
| 9/2016 | Artios Pharma | Series A | 0 |
| 11/2014 | Kuur Therapeutics | Series B | 78.5M |
| 7/2012 | Kuur Therapeutics | Venture Round | 26.4M |
| 10/2006 | InforSense | Venture Round | 10M |
| 4/2014 | Crescendo Biologics | Series A | 3.3M |
| 6/2014 | Cortexica Vision Systems | Venture Round | 2.5M |
| 8/2011 | Nexeon | Series C | 65.3M |
| 1/2016 | Silicon MicroGravity | Seed Round | 4.3M |
| 1/2015 | Veryan Medical | Series B | 0 |
| 3/2015 | Cortexica Vision Systems | Venture Round | 3.5M |
| 1/2016 | Inivata | Series A | 45.2M |
| 9/2006 | Lontra | Venture Round | - |
| 5/2014 | Puridify | Seed Round | 1.4M |
| 2/2016 | MISSION Therapeutics | Series C | 86.5M |
| 1/2011 | Novacem | Venture Round | 0 |
| 5/2015 | Akamis Bio | Series C | 38.8M |
| 8/2013 | Yoyo Wallet | Seed Round | 1.3M |
| 5/2016 | Nexeon | Private Equity Round | 43.2M |
| 12/1999 | Vivant | Series B | 11.6M |
| 12/2015 | Kesios Therapeutics | Series A | 28.4M |
| 6/2015 | Abingdon Health | Venture Round | 4.7M |
| 1/2013 | Musicmetric | Venture Round | 4.8M |
| 4/2010 | Veryan Medical | Series A | 5.4M |
| 1/2016 | import.io | Series A | 13M |
| 10/2015 | Telectic | Seed Round | 2.3M |
| 9/2009 | Kuur Therapeutics | Venture Round | 7.3M |
| 9/1999 | Pointshare | Series C | 40M |
| 8/2011 | MISSION Therapeutics | Series A | 6M |
| 10/2009 | Plaxica | Venture Round | 1.6M |
| 7/2007 | Veryan Medical | Venture Round | 6.2M |
| 6/2012 | Featurespace | Funding Round | 2.3M |
| 6/2014 | Featurespace | Funding Round | 5M |
| 12/2011 | TopiVert | Venture Round | 12.5M |
| 7/2016 | Oxular | Series A | 20.6M |
| 5/2015 | Enterprise Therapeutics | Series A | 3.8M |
| 6/2016 | Storm Therapeutics | Series A | 16M |
| 4/2011 | Circassia | Series D | 98M |
| 1/2008 | Circassia | Series B | 21.9M |
| 7/2013 | PolyTherics | Venture Round | 20.8M |
| 10/2011 | Veryan Medical | Venture Round | 8.1M |
| 9/2012 | Acunu | Venture Round | 5.8M |
| 3/2013 | Cambridge Communication Systems | Series A | 6.9M |
| 11/2016 | Enterprise Therapeutics | Venture Round | 5M |
| 1/2012 | Epsilon-3 Bio Ltd. | Series A | - |
| 5/2016 | Featurespace | Venture Round | 0 |
| 7/2011 | Stanmore Implants Worldwide | Funding Round | 6.5M |
| 7/2015 | Autifony Therapeutics | Series A | 12.4M |
| 10/2016 | Resolver | Series A | 0 |
| 12/2009 | Circassia | Series C | 24.8M |
| 2/2012 | Econic Technologies | Venture Round | 0 |
| 2/2016 | Oxular | Series A | 19.1M |
| 7/2011 | Stanmore Implants Worldwide | Venture Round | 6.5M |
| 8/2011 | Autifony Therapeutics | Funding Round | 16.5M |
| 9/2011 | PolyTherics | Venture Round | 3.4M |
| 11/2015 | WaveOptics | Series A | - |
| 1/2014 | TopiVert | Venture Round | 7.4M |
| 7/2014 | Lontra | Venture Round | 0 |
| 10/2014 | Kesios Therapeutics | Seed Round | 3M |
| 8/2015 | Oxford Biotrans | Series A | 3.9M |
| 4/2009 | Veryan Medical | Venture Round | 3.7M |
| 3/2013 | Impression Technologies | Seed Round | 761.5k |
| 9/2011 | Plaxica | Series B | 7.8M |
| 9/2013 | Plaxica | Series C | 12.6M |
| 1/2016 | SAM Labs | Seed Round | 4.5M |
| 6/2007 | PolyTherics | Venture Round | 4.6M |
| 5/2014 | Yoyo Wallet | Seed Round | 3.8M |
| 9/2014 | Inivata | Venture Round | 6.6M |
| 11/2010 | RepRegen | Venture Round | 1.6M |
| 10/2015 | Puridify | Series A | 3.4M |
| 8/2009 | Novacem | Venture Round | 1.7M |
| 1/2013 | Semetric | Venture Round | 4.7M |
| 7/2012 | Akamis Bio | Series B | 34.1M |
| 8/2011 | Autifony Therapeutics | Seed Round | 16.5M |
| 9/2016 | ThisWay | Seed Round | 0 |
| 11/2013 | Pulmocide | Series A | 27.6M |
| 3/2010 | Akamis Bio | Series A | 8.4M |
| 4/2010 | PolyTherics | Series C | 4M |
| 9/2011 | PolyTherics | Funding Round | 0 |
| 7/2016 | Abingdon Health | Venture Round | 0 |
| 5/2008 | Evince | Seed Round | 968k |
| 11/2016 | Enterprise Therapeutics | Venture Round | 0 |
| 10/2016 | Resolver | Series A | 0 |
| 9/2016 | ThisWay | Seed Round | 0 |
| 9/2016 | Concirrus | Series A | 0 |
| 9/2016 | Artios Pharma | Series A | 0 |
| 7/2016 | Oxular | Series A | 0 |
| 7/2016 | Abingdon Health | Venture Round | 0 |
| 7/2016 | Econic Technologies | Venture Round | 0 |
| 6/2016 | Storm Therapeutics | Series A | 0 |
| 5/2016 | Featurespace | Venture Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2010 | Investment Fund | $220.1M | 7/2013 | Debt | $45.3M |
European Investment Bank |
7/2015 | Debt | $77.7M |
European Investment Bank |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
